Panbela Therapeutics, Inc. (PBLA)
OTCMKTS: PBLA · Delayed Price · USD
0.540
-0.050 (-8.47%)
Apr 15, 2024, 3:57 PM EDT - Market closed
Panbela Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 3 | 0 | 2 | 20 | 28 | 24 | 326 | 713 | 2 | 3 | 0 | Upgrade
|
| Market Cap Growth | - | -99.87% | -92.59% | -26.42% | 14.99% | -92.66% | -54.23% | 39470.60% | -45.09% | 11294.44% | 9.09% | Upgrade
|
| Enterprise Value | 5 | 3 | 7 | 8 | 19 | 22 | 325 | 715 | 5 | 6 | 0 | Upgrade
|
| PE Ratio | -167.65 | 0.00 | -0.04 | -2.00 | -5.77 | -3.86 | -55.27 | -68.73 | -0.35 | -0.67 | -0.27 | Upgrade
|
| PS Ratio | - | - | - | - | - | - | - | - | - | - | 0.02 | Upgrade
|
| PB Ratio | -921.74 | 0.00 | -0.19 | 1.98 | 3.26 | 17.29 | 1217.69 | -193.29 | -0.39 | -1.22 | -0.14 | Upgrade
|
| P/FCF Ratio | -171.94 | 0.00 | -0.09 | -3.02 | -7.14 | -8.74 | -136.72 | -209.59 | -0.75 | -0.84 | -2.51 | Upgrade
|
| P/OCF Ratio | -171.94 | 0.00 | -0.10 | -3.02 | -7.14 | -8.74 | -136.72 | -209.59 | -0.75 | -0.84 | -2.51 | Upgrade
|
| EV/Sales Ratio | - | - | - | - | - | - | - | - | - | - | 0.33 | Upgrade
|
| EV/EBITDA Ratio | -131.50 | -0.05 | -0.20 | -0.79 | -3.59 | -4.89 | -74.86 | -118.82 | -0.90 | -1.05 | -7.15 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | -3.52 | -3.33 | - | - | -0.89 | -1.04 | -6.19 | Upgrade
|
| EV/FCF Ratio | -172.05 | -0.10 | -0.44 | -1.25 | -4.80 | -7.89 | -136.27 | -210.09 | -1.94 | -1.46 | -38.57 | Upgrade
|
| Debt / Equity Ratio | -1.10 | -1.10 | -0.85 | 0 | 0 | 0.08 | 1.31 | -0.49 | -0.71 | -1.24 | -2.73 | Upgrade
|
| Debt / EBITDA Ratio | -0.16 | -0.10 | -0.20 | - | - | -0.03 | -0.08 | -0.30 | -0.63 | -0.61 | -9.33 | Upgrade
|
| Debt / FCF Ratio | -0.21 | -0.21 | -0.43 | - | - | -0.04 | -0.15 | -0.54 | -1.37 | -0.85 | -50.36 | Upgrade
|
| Quick Ratio | 0.22 | 0.22 | 0.17 | 4.58 | 6.85 | 1.60 | 1.07 | 0.14 | 0.14 | 1.21 | 0.63 | Upgrade
|
| Current Ratio | 0.25 | 0.25 | 0.23 | 4.62 | 7.15 | 1.76 | 1.13 | 0.18 | 0.16 | 1.26 | 0.64 | Upgrade
|
| Asset Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.33 | Upgrade
|
| Interest Coverage | -97.83 | 161.81 | -118.38 | -910.00 | -338.47 | -1.97 | -2.14 | -3.72 | -28.71 | -29.75 | -2.12 | Upgrade
|
| Return on Equity (ROE) | 440.47% | 536.37% | 434.00% | -99.25% | -56.44% | -447.65% | -2203.36% | 281.21% | 110.12% | 183.77% | 50.74% | Upgrade
|
| Return on Assets (ROA) | -175.78% | -214.06% | -701.75% | -78.74% | -48.59% | -197.20% | -311.12% | -1352.54% | -582.90% | -272.51% | -26.29% | Upgrade
|
| Return on Capital (ROIC) | -6915.91% | -10597.93% | 2829.29% | -98.02% | -68.11% | -287.94% | -629.61% | 322.75% | 378.61% | -845.34% | -20.61% | Upgrade
|
| Earnings Yield | -791.28% | -1270106.82% | -2325.83% | -50.03% | -17.32% | -25.90% | -1.81% | -1.45% | -283.69% | -150.14% | -371.68% | Upgrade
|
| FCF Yield | -963.03% | -1269402.96% | -1061.02% | -33.10% | -14.00% | -11.44% | -0.73% | -0.48% | -133.08% | -118.75% | -39.77% | Upgrade
|
| Dividend Yield | 47.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Payout Ratio | -272.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Buyback Yield / Dilution | -17090783.81% | 87.32% | -75.72% | -51.42% | -35.66% | 93.89% | -30.76% | -14.75% | -120.90% | -876.67% | - | Upgrade
|
| Total Shareholder Return | -17090783.81% | 87.32% | -75.72% | -51.42% | -35.66% | 93.89% | -30.76% | -14.75% | -120.90% | -876.67% | - | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.